stock.name

Danaher Corp.

DHR

Market Cap$175.04B
Close$

Compare Danaher

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Danaher Corp.Danaher Corp.36.90.44%9%7.90.3
marketMarket Avg591.3%30%-1
IndustrialsIndustrials Avg240.99%21%30.6

Earnings Call Q4 2023

January 30, 2024 - AI Summary

Danaher reported better than anticipated core revenue in each of its segments in Q4 2023, led by strong performance in respiratory revenue at Cepheid.
The company exceeded margin and cash flow expectations for the quarter due to higher revenues and strong execution.
Danaher's full-year 2023 sales were $23.9 billion, with a core revenue decline of 10%, including a COVID-19 revenue headwind of approximately 9.5%.

Exclusive for Stockcircle Pro members

Sign upSign Up
$280.00

Target Price by Analysts

10.6% upsideDanaher Target Price DetailsTarget Price
$213.44

Current Fair Value

15.7% downside

Overvalued by 15.7% based on the discounted cash flow analysis.

Share Statistics

Market cap$175.04 Billion
Enterprise Value$187.57 Billion
Dividend Yield$1.0483 (0.44%)
Earnings per Share$6.38
Beta0.84
Outstanding Shares740,544,214
Avg 30 Day Volume2,510,179

Return

Return on Equity-
Return on Assets-
Return on Invested Capital-

Valuation & Multiples

P/E Ratio36.9
PEG-72.11
Price to Sales7.91
Price to Book Ratio3.52
Enterprise Value to Revenue7.85
Enterprise Value to EBIT36.06
Enterprise Value to Net Income39
Total Debt to Enterprise0.1
Debt to Equity0.34

Revenue Sources

No data

ESG Score

No data

About Danaher Corp.

2,020 employees
CEO: Rainer Blair